{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:54:14Z","timestamp":1791154454601,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.leukres.2006.09.008","type":"journal-article","created":{"date-parts":[[2006,10,20]],"date-time":"2006-10-20T13:11:40Z","timestamp":1161349900000},"page":"1199-1203","source":"Crossref","is-referenced-by-count":28,"title":["Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders"],"prefix":"10.1016","volume":"31","author":[{"given":"Akira","family":"Shimada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuho","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung-ja","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Minakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisei","family":"Kawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2006.09.008_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1203\/00006450-199808000-00019","article-title":"T cell activation deficiency associated with an aberrant pattern of protein tyrosine phosphorylation after CD3 perturbation in Down's syndrome","volume":"44","author":"Scotese","year":"1998","journal-title":"Pediatr Res"},{"key":"10.1016\/j.leukres.2006.09.008_bib2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1651-2227.2001.tb01601.x","article-title":"Thyroid dysfunction in children with Down's syndrome","volume":"90","author":"Tuysuz","year":"2001","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.leukres.2006.09.008_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/clin.1996.0031","article-title":"Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system?","volume":"78","author":"Cuadrado","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.leukres.2006.09.008_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0090-1229(92)90079-4","article-title":"Down syndrome [DS] peripheral blood contains phenotypically mature CD3+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+, and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus","volume":"62","author":"Murphy","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.leukres.2006.09.008_bib5","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1002\/j.1460-2075.1995.tb00181.x","article-title":"Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu\/Zn-superoxide dismutase: implications for Down syndrome","volume":"14","author":"Peled-Kamar","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.leukres.2006.09.008_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jpeds.2005.07.022","article-title":"Intrinsic abnormalities of lymphocyte counts in children with Down syndrome","volume":"147","author":"de Hingh","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.leukres.2006.09.008_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.10.048","article-title":"Interferon-gamma- and interleukin-4-producing T cells in Down's syndrome","volume":"395","author":"Franciotta","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.leukres.2006.09.008_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0404.1997.tb00275.x","article-title":"Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease","volume":"96","author":"Kalman","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.leukres.2006.09.008_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.72.2.233","article-title":"Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease","volume":"72","author":"Griffin","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.leukres.2006.09.008_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000063649","article-title":"Chemokines and pro-inflammatory cytokines in Down's syndrome: an early marker for Alzheimer-type dementia?","volume":"71","author":"Carta","year":"2002","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.leukres.2006.09.008_bib11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jnen\/63.7.679","article-title":"Trisomy 21 and the brain","volume":"63","author":"Mrak","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.leukres.2006.09.008_bib12","first-page":"241","article-title":"Syndromes of accelerated aging","volume":"60","author":"Martin","year":"1982","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1016\/j.leukres.2006.09.008_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood.V72.1.15.15","article-title":"Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome","volume":"72","author":"Hayashi","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.09.008_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2005.05700.x","article-title":"Optimizing therapy for myeloid disorders of Down syndrome","volume":"131","author":"Webb","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2006.09.008_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1525","article-title":"Origins of leukaemia in children with Down syndrome","volume":"5","author":"Hitzler","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2006.09.008_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00043426-200201000-00004","article-title":"Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study","volume":"24","author":"Al-Kasim","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.leukres.2006.09.008_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00431-004-1452-7","article-title":"Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome","volume":"163","author":"Dormann","year":"2004","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.leukres.2006.09.008_bib18","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","article-title":"A prospective study of the natural history of transient leukemia (TL) in neonates with down syndrome (DS): a children's oncology group (COG) study POG-9481","volume":"107","author":"Massey","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.09.008_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000075376","article-title":"Pro-inflammatory cytokinemia associated with transient myeloproliferative disorder in Down syndrome","volume":"85","author":"Shimada","year":"2004","journal-title":"Biol Neonate"},{"key":"10.1016\/j.leukres.2006.09.008_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2006.09.008_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V36.4.443.443","article-title":"A neonate with Down's syndrome and transient abnormal myelopoiesis: serial blood and bone marrow studies","volume":"36","author":"Nagao","year":"1970","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.09.008_bib22","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/clinchem\/43.9.1749","article-title":"Advanced multiplexed analysis with the FlowMetrix system","volume":"43","author":"Fulton","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.leukres.2006.09.008_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jim.2004.04.018","article-title":"Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1\/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants","volume":"291","author":"Prabhakar","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.leukres.2006.09.008_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1203\/00006450-199209000-00004","article-title":"A role for tumor necrosis factor-alpha and interferon-gamma in the regulation of interleukin-4-induced human thymocyte proliferation in vitro. Heightened sensitivity in the Down syndrome (trisomy 21) thymus","volume":"32","author":"Murphy","year":"1992","journal-title":"Pediatr Res"},{"key":"10.1016\/j.leukres.2006.09.008_bib25","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1073\/pnas.93.16.8530","article-title":"Constitutive overexpression of Cu\/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic-Cu\/Zn superoxide dismutase neurons","volume":"93","author":"Bar-Peled","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2006.09.008_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(01)02383-3","article-title":"Superoxide dismutases enhance H2O2-induced DNA damage and alter its site specificity","volume":"495","author":"Midorikawa","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.leukres.2006.09.008_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.2003.tb03136.x","article-title":"Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration","volume":"992","author":"Patel","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.leukres.2006.09.008_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0145-2126(94)90002-7","article-title":"Down's syndrome, interferon sensitivity and the development of leukaemia","volume":"18","author":"Zihni","year":"1994","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2006.09.008_bib29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0046-8177(99)90125-9","article-title":"Immunohistochemical study on transforming growth factor-beta1 expression in liver fibrosis of Down's syndrome with transient abnormal myelopoiesis","volume":"30","author":"Arai","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.leukres.2006.09.008_bib30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2141.2001.03093.x","article-title":"High expression of platelet-derived growth factor and transforming growth factor-beta 1 in blast cells from patients with Down Syndrome suffering from transient myeloproliferative disorder and organ fibrosis","volume":"115","author":"Hattori","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2006.09.008_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10428199509054751","article-title":"TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders","volume":"20","author":"Martyre","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2006.09.008_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2006.09.008_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2000.tb05373.x","article-title":"The role of pro- and anti-inflammatory cytokines in neurodegeneration","volume":"917","author":"Allan","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.leukres.2006.09.008_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000243942","article-title":"Soluble interleukin-2 receptor and interleukin-2 in human amniotic fluid of normal and abnormal pregnancies","volume":"63","author":"Shohat","year":"1993","journal-title":"Biol Neonate"},{"key":"10.1016\/j.leukres.2006.09.008_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.8755-8920.2000.440403.x","article-title":"Abnormal TGFbeta levels in the amniotic fluid of Down syndrome pregnancies","volume":"44","author":"Bromage","year":"2000","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.leukres.2006.09.008_bib36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood-2003-09-3219","article-title":"Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome","volume":"103","author":"Shimada","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.09.008_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08880019609033374","article-title":"Hydrops fetalis and neonatal leukemia in Down syndrome","volume":"13","author":"Zipursky","year":"1996","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.leukres.2006.09.008_bib38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0145-2126(95)00027-L","article-title":"Characteristic biological features of human megakaryoblastic leukaemia cell lines","volume":"19","author":"Hassan","year":"1995","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2006.09.008_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1182\/blood.V74.1.42.42","article-title":"Growth and differentiation of a human megakaryoblastic cell line, CMK","volume":"74","author":"Komatsu","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.09.008_bib40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcp.1041400219","article-title":"Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin","volume":"140","author":"Kitamura","year":"1989","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.leukres.2006.09.008_bib41","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.V76.10.1972.1972","article-title":"Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblasts","volume":"76","author":"Brach","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.09.008_bib42","first-page":"2217","article-title":"The role of type I and type II tumor necrosis factor [TNF] receptors in the ability of TNF-alpha to transduce a proliferative signal in the human megakaryoblastic leukemic cell line Mo7e","volume":"58","author":"Liu","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2006.09.008_bib43","first-page":"220","article-title":"Cytokines and their antagonists in myeloid disorders","volume":"32","author":"Estrov","year":"1995","journal-title":"Semin Hematol"},{"key":"10.1016\/j.leukres.2006.09.008_bib44","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2002-06-1890","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia","volume":"102","author":"Faderl","year":"2003","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606003468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606003468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T13:14:16Z","timestamp":1683638056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212606003468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0145212606003468"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2006.09.008","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}